Articles published by Biocept, Inc.


Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics
September 08, 2023
From Biocept, Inc.
Via Business Wire
Tickers
BIOC

Biocept to Participate in the H.C. Wainwright Global Investment Conference
September 05, 2023
From Biocept, Inc.
Via Business Wire
Tickers
BIOC


Biocept Reports Second Quarter 2023 Financial Results
August 14, 2023
From Biocept, Inc.
Via Business Wire
Tickers
BIOC






Biocept Announces One-for-Thirty Reverse Stock Split
May 17, 2023
From Biocept, Inc.
Via Business Wire
Tickers
BIOC

Biocept Reports First Quarter 2023 Financial Results
May 10, 2023
From Biocept, Inc.
Via Business Wire
Tickers
BIOC

Biocept Reports 2022 Financial Results
April 17, 2023
From Biocept, Inc.
Via Business Wire
Tickers
BIOC




Biocept Reports Third Quarter 2022 Financial Results
November 21, 2022
From Biocept, Inc.
Via Business Wire
Tickers
BIOC



Biocept Reports Second Quarter 2022 Financial Results
November 10, 2022
From Biocept, Inc.
Via Business Wire
Tickers
BIOC

Biocept to Present at the LD Micro Main Event XV
October 19, 2022
From Biocept, Inc.
Via Business Wire
Tickers
BIOC

Biocept Expands Commercial Offering of CNSide™ Assay to Most Cancers that Metastasize to the Central Nervous System
October 17, 2022
From Biocept, Inc.
Via Business Wire
Tickers
BIOC






Biocept Appoints RSM as Independent Auditor
June 27, 2022
From Biocept, Inc.
Via Business Wire
Tickers
BIOC

Biocept to Hold Business Strategy Conference Call Today
June 07, 2022
From Biocept, Inc.
Via Business Wire
Tickers
BIOC

Biocept Reports First Quarter 2022 Financial Results
May 23, 2022
From Biocept, Inc.
Via Business Wire
Tickers
BIOC
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.